Literature DB >> 18452441

Homozygote inositol transporter knockout mice show a lithium-like phenotype.

Yuly Bersudsky1, Alona Shaldubina, Galila Agam, Gerard T Berry, Robert H Belmaker.   

Abstract

OBJECTIVE: Lithium inhibits inositol monophosphatase and also reduces inositol transporter function. To determine if one or more of these mechanisms might underlie the behavioral effects of lithium, we studied inositol transporter knockout mice. We previously reported that heterozygous knockout mice with reduction of 15-37% in brain inositol had no abnormalities of pilocarpine sensitivity or antidepressant-like behavior in the Porsolt forced swim test. We now report on studies of homozygous inositol transporter knockout mice.
METHODS: Homozygote knockout mice were rescued by 2% inositol supplementation to the drinking water of the dam mice through pregnancy and lactation. Genotyping was carried out by polymerase chain reaction followed by agarose electrophoresis. Brain free myo-inositol levels were determined gas-chromatographically. Motor activity and coordination were assessed by the rotarod test. Behavior of the mice was studied in lithium-pilocarpine seizure models for lithium action and in the Porsolt forced swim test model for depression.
RESULTS: In homozygote knockout mice, free inositol levels were reduced by 55% in the frontal cortex and by 60% in the hippocampus. There were no differences in weight or motor coordination by the rotarod test. They behaved similarly to lithium-treated animals in the model of pilocarpine seizures and in the Porsolt forced swimming test model of depression.
CONCLUSIONS: Reduction of brain inositol more than 15-37% may be required to elicit lithium-like neurobehavioral effects.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18452441     DOI: 10.1111/j.1399-5618.2007.00546.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  12 in total

Review 1.  Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects.

Authors:  Jorge A Quiroz; Rodrigo Machado-Vieira; Carlos A Zarate; Husseini K Manji
Journal:  Neuropsychobiology       Date:  2010-05-07       Impact factor: 2.328

2.  Inositol-related gene knockouts mimic lithium's effect on mitochondrial function.

Authors:  Lilach Toker; Yuly Bersudsky; Inbar Plaschkes; Vered Chalifa-Caspi; Gerard T Berry; Roberto Buccafusca; Dieder Moechars; R H Belmaker; Galila Agam
Journal:  Neuropsychopharmacology       Date:  2013-08-08       Impact factor: 7.853

Review 3.  Validating GSK3 as an in vivo target of lithium action.

Authors:  W Timothy O'Brien; Peter S Klein
Journal:  Biochem Soc Trans       Date:  2009-10       Impact factor: 5.407

4.  Individual differences and evidence-based psychopharmacology.

Authors:  Rh Belmaker; Yuly Bersudsky; Galila Agam
Journal:  BMC Med       Date:  2012-09-27       Impact factor: 8.775

5.  myo-Inositol uptake is essential for bulk inositol phospholipid but not glycosylphosphatidylinositol synthesis in Trypanosoma brucei.

Authors:  Amaia Gonzalez-Salgado; Michael E Steinmann; Eva Greganova; Monika Rauch; Pascal Mäser; Erwin Sigel; Peter Bütikofer
Journal:  J Biol Chem       Date:  2012-02-20       Impact factor: 5.157

6.  Folate receptor alpha defect causes cerebral folate transport deficiency: a treatable neurodegenerative disorder associated with disturbed myelin metabolism.

Authors:  Robert Steinfeld; Marcel Grapp; Ralph Kraetzner; Steffi Dreha-Kulaczewski; Gunther Helms; Peter Dechent; Ron Wevers; Salvatore Grosso; Jutta Gärtner
Journal:  Am J Hum Genet       Date:  2009-09       Impact factor: 11.025

7.  KCNQ1, KCNE2, and Na+-coupled solute transporters form reciprocally regulating complexes that affect neuronal excitability.

Authors:  Geoffrey W Abbott; Kwok-Keung Tai; Daniel L Neverisky; Alex Hansler; Zhaoyang Hu; Torsten K Roepke; Daniel J Lerner; Qiuying Chen; Li Liu; Bojana Zupan; Miklos Toth; Robin Haynes; Xiaoping Huang; Didem Demirbas; Roberto Buccafusca; Steven S Gross; Vikram A Kanda; Gerard T Berry
Journal:  Sci Signal       Date:  2014-03-04       Impact factor: 8.192

Review 8.  Molecular actions and clinical pharmacogenetics of lithium therapy.

Authors:  Adem Can; Thomas G Schulze; Todd D Gould
Journal:  Pharmacol Biochem Behav       Date:  2014-02-15       Impact factor: 3.533

9.  Lithium promotes neural precursor cell proliferation: evidence for the involvement of the non-canonical GSK-3β-NF-AT signaling.

Authors:  Zhaoxia Qu; Dongming Sun; Wise Young
Journal:  Cell Biosci       Date:  2011-05-03       Impact factor: 7.133

Review 10.  The betaine/GABA transporter and betaine: roles in brain, kidney, and liver.

Authors:  Stephen A Kempson; Yun Zhou; Niels C Danbolt
Journal:  Front Physiol       Date:  2014-04-24       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.